<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=iso-8859-1">
<meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:AdvGulliv-R;
panose-1:0 0 0 0 0 0 0 0 0 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Texte de bulles Car";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.EmailStyle17
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:navy;}
span.EmailStyle18
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.TextedebullesCar
{mso-style-name:"Texte de bulles Car";
mso-style-priority:99;
mso-style-link:"Texte de bulles";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:595.3pt 841.9pt;
margin:70.85pt 3.0cm 70.85pt 3.0cm;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:287399118;
mso-list-type:hybrid;
mso-list-template-ids:-241169114 67764241 67764249 67764251 67764239 67764249 67764251 67764239 67764249 67764251;}
@list l0:level1
{mso-level-text:"%1\)";
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level2
{mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level3
{mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level4
{mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level5
{mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level6
{mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level7
{mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level8
{mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
@list l0:level9
{mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="2050" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=FR link=blue vlink=blue><div class=WordSection1><p style='background:white'><span lang=EN-US style='font-family:"Calibri","sans-serif"'>Dear all,<o:p></o:p></span></p><p style='background:white'><span lang=EN-US style='font-family:"Calibri","sans-serif"'>Concerning, <o:p></o:p></span></p><p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2'><![if !supportLists]><span lang=ES-TRAD style='font-family:"Calibri","sans-serif"'><span style='mso-list:Ignore'>1)<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span lang=ES-TRAD style='font-family:"Calibri","sans-serif"'>Asymptomatic Leishmaniasis<o:p></o:p></span></p><p class=MsoNormal style='margin-left:36.0pt'><span lang=ES-TRAD style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span lang=EN-US style='font-family:"Calibri","sans-serif"'>Please find in attach a manuscript in press that I hope some of you will find of interest <i>(“</i></span><i><span lang=EN-US style='font-family:"Calibri","sans-serif"'>Parasitic genotypes appear to differ in leishmaniasis patients compared with<o:p></o:p></span></i></p><p style='background:white'><i><span style='font-family:"Calibri","sans-serif"'>asymptomatic related carriers »).</span></i><i><span lang=EN-US style='font-family:"Calibri","sans-serif"'><o:p></o:p></span></i></p><p style='background:white'><span lang=EN-US style='font-family:"Calibri","sans-serif"'>Best regards,<o:p></o:p></span></p><p style='background:white'><span lang=EN-US style='font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><div><p style='background:white'><span lang=EN-US style='font-family:"Calibri","sans-serif"'>Mallorie<o:p></o:p></span></p><p style='background:white'><b><span lang=EN-US style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:purple'>*********************<br></span></b><b><span lang=EN-US style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'>Dr Mallorie HIDE, Ph.D</span></b><span lang=EN-US style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'> <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Calibri","sans-serif";color:black'><img width=152 height=106 id="Image_x0020_1" src="cid:image001.jpg@01CE1E5D.151EE0A0" alt="cid:image002.jpg@01CC7C61.E9921A40"></span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'> <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>MIVEGEC (CNRS 5290-IRD 224-UM1-UM2) </span><span lang=DE style='font-size:10.0pt;font-family:"Calibri","sans-serif";color:black'>(ex-GEMI UR165/UMR2724)</span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Calibri","sans-serif";color:black'>Equipe </span><b><span style='font-size:10.0pt;font-family:"Calibri","sans-serif";color:black'>Genesys</span></b><span style='font-size:10.0pt;font-family:"Calibri","sans-serif";color:black'> </span><span style='font-size:7.5pt;font-family:"Calibri","sans-serif";color:black'>(Génétique et Biodiversité des Systèmes Infectieux)</span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'> <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Calibri","sans-serif";color:black'>911 av Agropolis BP 64501, 34394 MONTPELLIER Cedex 5, FRANCE<br><br>Tel : (33)4.67.41.63.91<br>Fax : (33)4.67.41.62.99<br><br><a href="http://www.mivegec.ird.fr/" target="_blank">http://www.mivegec.ird.fr/</a></span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p></o:p></span></p><p class=MsoNormal><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:purple'>*********************</span></b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:black'><o:p></o:p></span></p></div><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>De :</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> leish-l-bounces@lineu.icb.usp.br [mailto:leish-l-bounces@lineu.icb.usp.br] <b>De la part de</b> Francisco Pasquau<br><b>Envoyé :</b> jeudi 14 février 2013 20:40<br><b>À :</b> 'Carlos Costa'; 'Leish-L'<br><b>Objet :</b> Re: [Leish-l] hot spots<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2'><![if !supportLists]><span lang=ES-TRAD style='font-family:"Arial","sans-serif";color:navy'><span style='mso-list:Ignore'>2)<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span lang=ES-TRAD style='font-family:"Arial","sans-serif";color:navy'>Asymptomatic Leishmaniasis<o:p></o:p></span></p><p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2'><![if !supportLists]><span lang=EN-GB style='font-family:"Arial","sans-serif";color:navy'><span style='mso-list:Ignore'>3)<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span lang=EN-GB style='font-family:"Arial","sans-serif";color:navy'>Secondary Prophylaxis in immunosuppressed patient with Visceral Leishmaniasis (HIV, Transplant, anti TNF therapy…) <o:p></o:p></span></p><p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2'><![if !supportLists]><span lang=ES-TRAD style='font-family:"Arial","sans-serif";color:navy'><span style='mso-list:Ignore'>4)<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span lang=ES style='font-family:"Arial","sans-serif";color:navy'>“Active chronic visceral Leishmaniasis” </span><span lang=ES-TRAD style='font-family:"Arial","sans-serif";color:navy'><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Arial","sans-serif";color:navy'><o:p> </o:p></span></p><p class=MsoNormal style='margin-left:18.0pt'><span lang=PT-BR style='font-family:"Arial","sans-serif";color:navy'>F.Pasquau Liaño<o:p></o:p></span></p><p class=MsoNormal style='margin-left:18.0pt'><span lang=PT-BR style='font-family:"Arial","sans-serif";color:navy'>Hospital Marina Baixa<o:p></o:p></span></p><p class=MsoNormal style='margin-left:18.0pt'><span lang=PT-BR style='font-family:"Arial","sans-serif";color:navy'>Alicante. Spain<o:p></o:p></span></p><div><div class=MsoNormal align=center style='text-align:center'><span lang=ES><hr size=2 width="100%" align=center></span></div><p class=MsoNormal><b><span lang=ES style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>De:</span></b><span lang=ES style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> <a href="mailto:leish-l-bounces@lineu.icb.usp.br">leish-l-bounces@lineu.icb.usp.br</a> [<a href="mailto:leish-l-bounces@lineu.icb.usp.br">mailto:leish-l-bounces@lineu.icb.usp.br</a>] <b>En nombre de </b>Carlos Costa<br><b>Enviado el:</b> jueves, 07 de febrero de 2013 8:39<br><b>Para:</b> Leish-L<br><b>Asunto:</b> [Leish-l] hot spots</span><span lang=ES><o:p></o:p></span></p></div><p class=MsoNormal><span lang=ES-TRAD><o:p> </o:p></span></p><div><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif";color:black'>What are the most polemic issues in leishmaniasis?<br clear=all></span><span lang=ES-TRAD><o:p></o:p></span></p><div><p class=MsoNormal><span lang=ES-TRAD><o:p> </o:p></span></p></div><p class=MsoNormal><span lang=ES-TRAD>-- <o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Carlos H. N. Costa, MD, DSc.</span><span lang=ES-TRAD><o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Sociedade Brasileira de Medicina Tropical </span><span lang=ES-TRAD><o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>(Brazilian Society of Tropical Medicine)</span><span lang=ES-TRAD><o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>President</span><span lang=ES-TRAD><o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD><o:p> </o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Universidade Federal do Piauí</span><span lang=ES-TRAD><o:p></o:p></span></p><div><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Instituto de Doenças Tropicais Natan Portella</span><span lang=ES-TRAD><o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Rua Artur de Vasconcelos 151-Sul</span><span lang=ES-TRAD><o:p></o:p></span></p><div><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>64001-450 Teresina-PI</span><span lang=ES-TRAD><o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Brazil<o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>Telephones: +55 86 3222-4377 (W), <o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center'><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>+55 86 3221-3062 (W), <o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center'><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'>+55 86 3237-1075 (R). <o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-family:"Verdana","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Aviso: As informações contidas nesta mensagem são CONFIDENCIAIS, protegidas pelo sigilo legal, por direitos autorais e destinadas exclusivamente à pessoa ou organização para a qual a mensagem foi destinada.<o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Warning: This message is meant only for the intended recipient of the transmission. It is forbidden any unauthorized use, alteration, reproduction and distribution. If you are not the correct recipient, please notify us immediately by return e-mail and delete this message from your system.<o:p></o:p></span></p></div></div></div><p class=MsoNormal><span lang=ES-TRAD><br><br>---------------------------------------------------------------------------------------------------<br><b>Texto añadido por Panda GP 2013:</b><br><br>Este mensaje NO ha sido clasificado como SPAM. Si se trata de un mensaje de correo no solicitado (SPAM), haz clic en el siguiente vínculo para reclasificarlo: <a href="http://localhost:6083/Panda?ID=pav_492&SPAM=true&path=C:\Documents%20and%20Settings\Curro\Configuración%20local\Datos%20de%20programa\Panda%20Security\Panda%20Global%20Protection%202013\AntiSpam">¡Es SPAM!</a><br>---------------------------------------------------------------------------------------------------<o:p></o:p></span></p><p class=MsoNormal><span lang=ES-TRAD><br><br>--<br><i>This email was sent by icb.usp.br </i> <o:p></o:p></span></p></div></body></html>